Annual Drug Patent Expirations for BLUDIGO
Bludigo is a drug marketed by Provepharm Sas and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in BLUDIGO is indigotindisulfonate sodium. One supplier is listed for this compound. Additional details are available on the indigotindisulfonate sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
